Readers' Forum
Haemolytic and nonhaemolytic jaundice revisited
Michael Kaplan,
Corresponding Author
Michael Kaplan
Faculty of Medicine of the Hebrew University, Mevasseret Zion, Israel
Emeritus Director of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel
Correspondence
Michael Kaplan, Faculty of Medicine of the Hebrew University, 20 Sheshet Hayamim St, Mevasseret Zion 9073019, Israel.
Tel/Fax: +972 2 534 4268 |
Email: [email protected]
Search for more papers by this author
Michael Kaplan,
Corresponding Author
Michael Kaplan
Faculty of Medicine of the Hebrew University, Mevasseret Zion, Israel
Emeritus Director of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel
Correspondence
Michael Kaplan, Faculty of Medicine of the Hebrew University, 20 Sheshet Hayamim St, Mevasseret Zion 9073019, Israel.
Tel/Fax: +972 2 534 4268 |
Email: [email protected]
Search for more papers by this author
First published: 30 December 2016
No abstract is available for this article.
References
- 1Lee BK, Le Ray I, Sun JY, Wikman A, Reilly M, Johansson S. Haemolytic and non-haemolytic neonatal jaundice have different risk factor profiles. Acta Paediatr 2016; 105: 1444–50.
- 2Bhutani VK, Wong RJ. Risk profiles for haemolytic and nonhaemolytic jaundice. Acta Paediatr 2016; 105: 1387–8.
- 3Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Hemolysis and hyperbilirubinemia in direct antiglobulin positive, ABO blood group heterospecific neonates. J Pediatr 2010; 157: 772–7.
